Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients

S D'Sa, JV Matous, R Advani, C Buske, JJ Castillo… - Seminars in …, 2023 - Elsevier
Abstract The consensus panel 2 (CP2) of the 11th International Workshop on Waldenström's
macroglobulinemia (IWWM-11) has reviewed and incorporated current data to update the …

[HTML][HTML] Stigma of palliative care among patients with advanced cancer and their caregivers on early palliative care

E Bandieri, E Borelli, F Gilioli, S Bigi, C Mucciarini… - Cancers, 2023 - mdpi.com
Simple Summary Early palliative care represents a successful model of care for advanced
cancer patients and their caregivers. Yet, early palliative care provision remains confined to …

[HTML][HTML] Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies

M Tsang, K Bischoff, KL Schoenbeck, K Berry… - Blood …, 2023 - ncbi.nlm.nih.gov
Hematologic malignancies are heterogeneous and have unpredictable illness trajectories.
Intensive therapies, such as hematopoietic stem cell transplant (HSCT) and chimeric antigen …

[HTML][HTML] A multicentre survey on the perception of palliative care among health professionals working in haematology

S Di Lorenzo, L Mozzi, F Salmaso, C Silvagni… - Supportive Care in …, 2024 - Springer
Purpose Patients with haematologic malignancies have less access to palliative care and
are referred later than patients with solid tumours. We developed a survey to investigate this …

[HTML][HTML] Palliative care for patients with hematological malignancies—beyond specialist care

A Shaulov, A Aviv - Annals of Palliative Medicine, 2023 - apm.amegroups.org
Palliative care for patients with hematological malignancies—beyond specialist care -
Shaulov - Annals of Palliative Medicine Have a website account?Log In orRegister for …